Disregarding the quality, third-party testing, and FSSAI certification of the supplement
Aardvark Therapeutics Sector: Oral gut-restricted bitter taste receptor agonists for hunger suppression HQ: San Diego, CA Year Founded: 2017 Origin Story: Aardvark Therapeutics was founded around a mechanistically distinct hypothesis: rather than suppressing appetite like GLP-1 drugs, the companys lead compound activates bitter taste receptors (TAS2Rs) confined to the gastrointestinal tract to trigger local release of satiety hormones, targeting hunger itself without systemic drug exposure
Mller TD, Finan B, Bloom SR, et al
This front-loading strategy aims to rapidly establish therapeutic tissue concentrations
The very first step is often the simplest: a clean, secure login that takes you directly to your personalized dashboard
Today, the word peptide has come to describe experimental, grey market drugs that are often manufactured in China and peddled by websites claiming to sell them for research use